Elicio Therapeutics, Inc. (ELTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $16.0K | -81.6% |
| 2024 | $87.0K | +31.8% |
| 2023 | $66.0K | -89.9% |
| 2022 | $654.0K | +71.2% |
| 2021 | $382.0K | +831.7% |
| 2020 | $41.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $16.0K | -81.6% |
| 2024 | $87.0K | +31.8% |
| 2023 | $66.0K | -89.9% |
| 2022 | $654.0K | +71.2% |
| 2021 | $382.0K | +831.7% |
| 2020 | $41.0K | — |